Search CDMOs

• API Synthesis & Manufacturing
• Sterile Fill-Finish & Aseptic Manufacturing
• Formulation Development

U.S.-based biopharmaceutical company offering oral solid dosage, injectables, and API manufacturing with FDA-approved facilities across the U.S. and India, including advanced capabilities in lyophilization, aseptic processing, and oncology formulations.

• CMC Analytical Development
• Cell Therapy Manufacturing
• CMC Regulatory Submission Support

Leading cell therapy CDMO delivering GMP manufacturing, analytics, and CMC strategy from early development through commercial launch across purpose-built U.S. facilities.

• Allogeneic Cell Therapy Manufacturing
• Autologous Cell Therapy Manufacturing
• Cell Therapy Manufacturing

Enable Biotech provides clinical GMP manufacturing for cell therapies, exosome therapies, and gene therapies, with SwissMedic accreditation pending for gene therapy operations as of summer 2024.

• Allogeneic Cell Therapy Manufacturing
• CMC Analytical Development
• Cell-Line Development

Cellistic is an iPSC-focused CDMO offering integrated cell line development, process development, and GMP manufacturing for allogeneic cell therapy and regenerative medicine programs. The company operates a purpose-built, EMA-certified and FDA/PMDA-compliant manufacturing facility in Belgium.

• CMC Analytical Development
• Biologics Development & Manufacturing
• Cell-Line Development

U.S.-based CDMO offering end-to-end biomanufacturing services for antibodies, recombinant proteins, vaccines, and other biologics modalities, with dedicated microbial and mammalian facilities and in-house cell line development capabilities.

• Downstream Processing
• Sterile Fill-Finish & Aseptic Manufacturing
• Formulation Development

CDMO specializing in liposome and lipid nanoparticle (LNP) formulation development and GMP manufacturing from bench to commercial scale, with mRNA process development and aseptic fill-finish capabilities.

• CMC Analytical Development
• API Synthesis & Manufacturing
• CMC Regulatory Submission Support

CMC Pharma provides integrated formulation development, analytical testing, stability studies, and cGMP manufacturing oversight for small molecule drug programs from preclinical through post-approval, with hands-on regulatory expertise and CMO management built in.

• CMC Analytical Development
• Controlled Substance Manufacturing
• Formulation Development

Independent, family-owned CDMO specializing in oral solids, semi-solids, and controlled-substance manufacturing with 475,000 sq ft cGMP facility in Bristol, TN; over 80 products commercialized.

• CMC Analytical Development
• Cell-Line Development
• CMC Regulatory Submission Support

GMP CDMO specializing in plasmid DNA, mRNA, and recombinant protein manufacturing from gene construction to market supply, with in-house mRNA lipid-nanoparticle formulation and aseptic fill-finish capabilities.

• CMC Analytical Development
• API Synthesis & Manufacturing
• CMC Regulatory Submission Support

India's largest CDMO with 15+ state-of-the-art facilities and 30% domestic market share, manufacturing 4,100+ formulations across tablets, capsules, injectables, APIs, and specialty dosage forms under WHO-GMP, USFDA, EU-GMP, and TGA compliance.

• CMC Analytical Development
• CMC Regulatory Submission Support
• Sterile Fill-Finish & Aseptic Manufacturing

Ascendia is a specialty CDMO providing formulation development, analytical services, and GMP manufacturing for small molecules and biologics from pre-formulation through commercialization, with proprietary nanotechnologies including LipidSol, EmulSol, AmorSol, and NanoSol.

• ADC (Antibody-Drug Conjugate) Manufacturing
• CMC Analytical Development
• API Synthesis & Manufacturing

Ardena is an integrated CDMO and bioanalytical CRO specializing in advanced drug product development, nanomedicine, and bioanalysis for complex molecules including poorly soluble compounds, highly potent APIs, and controlled substances.

• Allogeneic Cell Therapy Manufacturing
• CMC Analytical Development
• Autologous Cell Therapy Manufacturing

Cellares operates a global network of Smart Factories delivering integrated development and manufacturing (IDMO) services for cell therapies, with proprietary Cell Shuttle® and Cell Q™ platforms enabling cGMP-compliant, automated manufacturing and quality control at clinical and commercial scale.

• ADC Payload & Linker Synthesis
• API Synthesis & Manufacturing
• Bioconjugation Services

Fluorochem supplies over 400,000 high-quality chemicals and reagents globally, with custom synthesis and contract manufacturing capabilities for pharmaceutical and life sciences research.

• CMC Analytical Development
• Cell-Line Development
• CMC Regulatory Submission Support

European CDMO specializing in microbial and precision fermentation up to 40,000 L across two integrated sites (Pamplona, Spain and Basel, Switzerland), with core strengths in E. coli expression, animal health biologics, probiotics, and complex CMC programs requiring scale-up discipline and impurity control.

• Downstream Processing
• Microbial Fermentation
• Process Development

Bailun manufactures GMP-compliant bioreactors and fermentation systems from lab scale (0.5 mL) to 5000 L industrial capacity, with 25+ years of experience serving pharmaceutical, vaccine, and precision fermentation applications across 100+ global projects.

• Allogeneic Cell Therapy Manufacturing
• CMC Analytical Development
• Autologous Cell Therapy Manufacturing

Cell-Easy is a CDMO specializing in development and GMP manufacturing of cell therapies, with expertise across T cells, NK cells, MSCs, and iPSCs. The company has manufactured over 1,000 clinical doses and supports 50+ development programs from process optimization through regulatory compliance.

• CMC Analytical Development
• Cell-Line Development
• Cell Therapy Manufacturing

Cell therapy CDMO offering end-to-end development, GMP manufacturing, and regulatory support from preclinical through commercial scale, with specialized expertise in T cells, NK cells, MSCs, iPSCs, and other cell modalities.